Century Therapeutics Inc (IPSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 1,396 | 1,058 | 0 | 0 | 0 |
| Gross Profit | 1,396 | 1,058 | N/A | N/A | N/A |
| Operating Expenses | 32,747 | 38,494 | 27,973 | 25,827 | 23,021 |
| Operating Income | -31,351 | -37,436 | -27,973 | -25,827 | -23,021 |
| Interest Expense | 330 | 314 | 321 | 322 | 318 |
| Other Income | 711 | 253 | 143 | 140 | 66 |
| Pre-tax Income | -30,970 | -37,497 | -28,151 | -26,009 | -23,273 |
| Income Tax | 18 | 16 | N/A | N/A | N/A |
| Net Income Continuous | -30,988 | -37,513 | -28,194 | -26,009 | -23,273 |
| Net Income | $-30,988 | $-37,513 | $-28,194 | $-26,009 | $-23,273 |
| EPS Basic Total Ops | -0.54 | -0.66 | 1.84 | -0.48 | -1.93 |
| EPS Basic Continuous Ops | -0.54 | -0.66 | 1.84 | -0.48 | -1.93 |
| EPS Diluted Total Ops | -0.54 | -0.66 | 1.84 | -0.48 | -1.93 |
| EPS Diluted Continuous Ops | -0.54 | -0.66 | 1.84 | -0.48 | -1.93 |
| EBITDA(a) | $-29,607 | $-36,200 | $-26,845 | $-24,706 | $-22,009 |